Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-04-14 @ 6:45 PM
Study NCT ID:
NCT06374602
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2024-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Sponsor:
Saint Petersburg State University, Russia